{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T16:18:42Z","timestamp":1767889122743,"version":"3.49.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.ejphar.2016.03.034","type":"journal-article","created":{"date-parts":[[2016,3,19]],"date-time":"2016-03-19T12:48:38Z","timestamp":1458391718000},"page":"71-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Involvement of nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of tropisetron and ondansetron in mice forced swimming test and tail suspension test"],"prefix":"10.1016","volume":"780","author":[{"given":"Arya","family":"Haj-Mirzaian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nastaran","family":"Kordjazy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shayan","family":"Amiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arvin","family":"Haj-Mirzaian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossien","family":"Amini-khoei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sattar","family":"Ostadhadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AhmadReza","family":"Dehpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2016.03.034_bib1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.physbeh.2015.03.032","article-title":"Co-occurrence of anxiety and depressive-like behaviors following adolescent social isolation in male mice; possible role of nitrergic system","volume":"145","author":"Amiri","year":"2015","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejphar.2016.03.034_bib2","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1016\/j.bbagen.2015.09.009","article-title":"Tropisetron attenuated the anxiogenic effects of social isolation by modulating nitrergic system and mitochondrial function","volume":"1850","author":"Amiri","year":"2015","journal-title":"Biochim. Biophys. Acta (BBA) \u2013 Gen. Subj."},{"key":"10.1016\/j.ejphar.2016.03.034_bib3","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1370\/afm.349","article-title":"Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis","volume":"3","author":"Arroll","year":"2005","journal-title":"Ann. Fam. Med."},{"key":"10.1016\/j.ejphar.2016.03.034_bib4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrn1846","article-title":"New approaches to antidepressant drug discovery: beyond monoamines","volume":"7","author":"Berton","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2016.03.034_bib5","doi-asserted-by":"crossref","first-page":"348","DOI":"10.4103\/0253-7613.115014","article-title":"Antidepressant-like effect of novel 5-HT3 receptor antagonist Nn-butyl-3-ethoxyquinoxalin-2-carboxamide (6p): an approach using rodent behavioral antidepressant tests","volume":"45","author":"Bhatt","year":"2013","journal-title":"Indian J. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.03.034_bib6","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0306-4522(03)00217-3","article-title":"Species, strain and developmental variations in hippocampal neuronal and endothelial nitric oxide synthase clarify discrepancies in nitric oxide-dependent synaptic plasticity","volume":"119","author":"Blackshaw","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2016.03.034_bib7","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.pbb.2006.09.003","article-title":"Acute treatment with 5-HT3 receptor antagonist, tropisetron, reduces immobility in intact female rats exposed to the forced swim test","volume":"85","author":"Bravo","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2016.03.034_bib8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-2007-999142","article-title":"Ondansetron--the first highly selective 5-HT3 antagonist in therapy of psychiatric diseases","volume":"60","author":"Broocks","year":"1992","journal-title":"Fortschritte der Neurologie-Psychiatrie"},{"key":"10.1016\/j.ejphar.2016.03.034_bib9","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1176\/ajp.2006.163.12.2141","article-title":"Changes in the prevalence of major depression and comorbid substance use disorders in the United States between 1991\u20131992 and 2001\u20132002","volume":"163","author":"Compton","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2016.03.034_bib10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","article-title":"Assessing antidepressant activity in rodents: recent developments and future needs","volume":"23","author":"Cryan","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2016.03.034_bib11","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.neubiorev.2005.03.009","article-title":"The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2016.03.034_bib12","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1097\/00001756-200011270-00022","article-title":"Evidence for dual effects of nitric oxide in the forced swimming test and in the tail suspension test in mice","volume":"11","author":"da Silva","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.ejphar.2016.03.034_bib13","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0005-2728(99)00024-9","article-title":"Guanylate cyclase and the NO\/cGMP signaling pathway","volume":"1411","author":"Denninger","year":"1999","journal-title":"Biochim. Biophys. Acta (BBA) \u2013 Bioenerg."},{"key":"10.1016\/j.ejphar.2016.03.034_bib14","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.pnpbp.2007.02.008","article-title":"Involvement of l-arginine\u2013nitric oxide\u2013cyclic guanosine monophosphate pathway in the antidepressant-like effect of venlafaxine in mice","volume":"31","author":"Dhir","year":"2007","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2016.03.034_bib15","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1097\/00001756-200006260-00008","article-title":"Acute treatments with GMP produce antidepressant-like effects in mice","volume":"11","author":"Eckeli","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.ejphar.2016.03.034_bib16","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.ph.57.030195.003343","article-title":"Nitric oxide signaling in the central nervous system","volume":"57","author":"Garthwaite","year":"1995","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.ejphar.2016.03.034_bib17","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.euroneuro.2007.07.011","article-title":"Nitric oxide involvement in the antidepressant-like effects of acute lithium administration in the mouse forced swimming test","volume":"18","author":"Ghasemi","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2016.03.034_bib18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.seizure.2009.10.006","article-title":"Seizure susceptibility alteration through 5-HT3 receptor: modulation by nitric oxide","volume":"19","author":"Gholipour","year":"2010","journal-title":"Seizure"},{"key":"10.1016\/j.ejphar.2016.03.034_bib19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.36076\/ppj.2004\/7\/141","article-title":"Serotonin 5-HT(3) receptor mediation of pain and anti-nociception: implications for clinical therapeutics","volume":"7","author":"Giordano","year":"2004","journal-title":"Pain Physician"},{"key":"10.1016\/j.ejphar.2016.03.034_bib20","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0076-6879(96)68016-1","article-title":"Measurement of nitrate and nitrite in biological samples using nitrate reductase and Griess reaction","volume":"268","author":"Granger","year":"1996","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ejphar.2016.03.034_bib21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2165\/00003495-199753010-00003","article-title":"The non-antiemetic uses of serotonin 5-HT3 receptor antagonists","volume":"53","author":"Greenshaw","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2016.03.034_bib22","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pneurobio.2005.06.001","article-title":"The physiology and pathophysiology of nitric oxide in the brain","volume":"76","author":"Guix","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejphar.2016.03.034_bib23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.pbb.2014.05.024","article-title":"5HT3 receptor antagonist (ondansetron) reverses depressive behavior evoked by chronic unpredictable stress in mice: modulation of hypothalamic-pituitary-adrenocortical and brain serotonergic system","volume":"124","author":"Gupta","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2016.03.034_bib24","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejphar.2015.01.006","article-title":"Blockade of NMDA receptors reverses the depressant, but not anxiogenic effect of adolescence social isolation in mice","volume":"750","author":"Haj-Mirzaian","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.03.034_bib25","first-page":"1","article-title":"Evidence for the involvement of NMDA receptors in the antidepressant-like effect of nicotine in mouse forced swimming and tail suspension tests","author":"Haj-Mirzaian","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2016.03.034_bib26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejphar.2014.03.053","article-title":"Opioid\/NMDA receptors blockade reverses the depressant-like behavior of foot shock stress in the mouse forced swimming test","volume":"735","author":"Haj-Mirzaian","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.03.034_bib27","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.euroneuro.2003.08.010","article-title":"Nitric oxide synthase inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test","volume":"14","author":"Harkin","year":"2004","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2016.03.034_bib28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0014-2999(99)00191-0","article-title":"Nitric oxide synthase inhibitors have antidepressant-like properties in mice: 1. Acute treatments are active in the forced swim test","volume":"372","author":"Harkin","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.03.034_bib29","first-page":"494","article-title":"Stress\u2013restress evokes sustained iNOS activity and altered GABA levels and NMDA receptors in rat hippocampus","volume":"175","author":"Harvey","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2016.03.034_bib30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/030097400446652","article-title":"Oral treatment of fibromyalgia with tropisetron given over 28 days: influence on functional and vegetative symptoms, psychometric parameters and pain","volume":"29","author":"Haus","year":"2000","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.ejphar.2016.03.034_bib31","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0166-4328(02)00084-0","article-title":"Reduction of cGMP and nitric oxide has antidepressant-like effects in the forced swimming test in rats","volume":"134","author":"Heiberg","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2016.03.034_bib32","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.4088\/JCP.v64n0907","article-title":"Pilot trial of ondansetron in the treatment of 8 patients with obsessive-compulsive disorder","volume":"64","author":"Hewlett","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ejphar.2016.03.034_bib33","first-page":"197","article-title":"5-HT receptors: subtypes and second messengers","volume":"11","author":"Hoyer","year":"1991","journal-title":"J. Recept. Signal Transduct."},{"key":"10.1016\/j.ejphar.2016.03.034_bib34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.brainres.2011.08.006","article-title":"Involvement of nitric oxide in granisetron improving effect on scopolamine-induced memory impairment in mice","volume":"1429","author":"Javadi-Paydar","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2016.03.034_bib35","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00213-006-0326-2","article-title":"Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects","volume":"185","author":"Joca","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2016.03.034_bib36","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0006-3223(03)00319-6","article-title":"Depressed new neurons?\u2014Adult hippocampal neurogenesis and a cellular plasticity hypothesis of major depression","volume":"54","author":"Kempermann","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2016.03.034_bib37","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ejphar.2015.06.030","article-title":"Elevated level of nitric oxide mediates the anti-depressant effect of rubidium chloride in mice","volume":"762","author":"Kordjazy","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.03.034_bib38","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.physbeh.2014.05.006","article-title":"Assessment of mouse anxiety-like behavior in the light-dark box and open-field arena: role of equipment and procedure","volume":"133","author":"Kulesskaya","year":"2014","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejphar.2016.03.034_bib39","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/jphp.12163","article-title":"QCM\u20104 a novel 5\u2010HT3 antagonist attenuates the behavioral and biochemical alterations on chronic unpredictable mild stress model of depression in Swiss albino mice","volume":"66","author":"Kurhe","year":"2014","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.03.034_bib40","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF02247373","article-title":"A randomized double-blind placebo-controlled study of tropisetron in the treatment of outpatients with generalized anxiety disorder","volume":"112","author":"Lecrubier","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2016.03.034_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2014.01.030","article-title":"The pattern of glutamate-induced nitric oxide dynamics in vivo and its correlation with nNOS expression in rat hippocampus, cerebral cortex and striatum","volume":"1554","author":"Louren\u00e7o","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2016.03.034_bib43","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/cbdd.12271","article-title":"Design, synthesis and evaluation of antidepressant activity of novel 2\u2010methoxy 1, 8 naphthyridine 3\u2010carboxamides as 5\u2010HT3 receptor antagonists","volume":"83","author":"Mahesh","year":"2014","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejphar.2016.03.034_bib44","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0014-2999(92)90074-E","article-title":"5-HT3 receptor antagonists reverse helpless behaviour in rats","volume":"212","author":"Martin","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.03.034_bib45","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jpsychires.2011.11.009","article-title":"Ascorbic acid treatment, similarly to fluoxetine, reverses depressive-like behavior and brain oxidative damage induced by chronic unpredictable stress","volume":"46","author":"Moretti","year":"2012","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.ejphar.2016.03.034_bib46","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0006-8993(97)01459-5","article-title":"The 5-HT3 receptor agonist attenuates the action of antidepressants in the forced swim test in rats","volume":"786","author":"Nakagawa","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2016.03.034_bib47","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0306-4522(98)00520-X","article-title":"Calcium changes induced by presynaptic 5-hydroxytryptamine-3 serotonin receptors on isolated terminals from various regions of the rat brain","volume":"91","author":"Nayak","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2016.03.034_bib48","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1046\/j.1471-4159.2000.740785.x","article-title":"Chronic stress induces the expression of inducible nitric oxide synthase in rat brain cortex","volume":"74","author":"Olivenza","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2016.03.034_bib49","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Archives internationales de pharmacodynamie et de th\u00e9rapie"},{"key":"10.1016\/j.ejphar.2016.03.034_bib50","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1177\/0269881109348161","article-title":"Review: the auspicious role of the 5-HT3 receptor in depression: a probable neuronal target?","volume":"24","author":"Rajkumar","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2016.03.034_bib51","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/FBP.0b013e3282f3cfd4","article-title":"Antidepressant-like effects of serotonin type-3 antagonist, ondansetron: an investigation in behaviour-based rodent models","volume":"19","author":"Ramamoorthy","year":"2008","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.03.034_bib52","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.bbr.2011.06.011","article-title":"Antidepressant-like effect of pioglitazone in the forced swimming test in mice: the role of PPAR-gamma receptor and nitric oxide pathway","volume":"224","author":"Sadaghiani","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2016.03.034_bib53","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/nn1969","article-title":"Adult hippocampal neurogenesis in depression","volume":"10","author":"Sahay","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejphar.2016.03.034_bib54","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/00001756-200205070-00020","article-title":"Glutamate and NO mediation of the pressor response to 5-HT3 receptor stimulation in the nucleus tractus solitarii","volume":"13","author":"S\u00e9voz-Couche","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.ejphar.2016.03.034_bib55","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1590\/1516-4446-2013-1294","article-title":"Prevalence of depression morbidity among Brazilian adults: a systematic review and meta-analysis","volume":"36","author":"Silva","year":"2014","journal-title":"Revista Brasileira de Psiquiatria"},{"key":"10.1016\/j.ejphar.2016.03.034_bib56","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.pbb.2007.08.008","article-title":"Nitric oxide-mediated anxiolytic-like and antidepressant-like effects in animal models of anxiety and depression","volume":"88","author":"Spiacci","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2016.03.034_bib57","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/1073858410366481","article-title":"Nitric oxide signaling in brain function, dysfunction, and dementia","volume":"16","author":"Steinert","year":"2010","journal-title":"Neuroscientist"},{"key":"10.1016\/j.ejphar.2016.03.034_bib58","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2016.03.034_bib59","first-page":"600","article-title":"Administration of substances to laboratory animals: routes of administration and factors to consider","volume":"50","author":"Turner","year":"2011","journal-title":"J. Am. Assoc. Lab. Anim. Sci.: JAALAS"},{"key":"10.1016\/j.ejphar.2016.03.034_bib60","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/hipo.20156","article-title":"Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment","volume":"16","author":"Warner-Schmidt","year":"2006","journal-title":"Hippocampus"},{"key":"10.1016\/j.ejphar.2016.03.034_bib61","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/sj.bjp.0703349","article-title":"Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo","volume":"130","author":"Wegener","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.03.034_bib62","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1210\/mend.12.9.0163","article-title":"Functional antagonism of gonadal steroids at the 5-hydroxytryptamine type 3 receptor","volume":"12","author":"Wetzel","year":"1998","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ejphar.2016.03.034_bib63","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1111\/j.1471-4159.2007.04914.x","article-title":"Neuronal nitric oxide synthase contributes to chronic stress-induced depression by suppressing hippocampal neurogenesis","volume":"103","author":"Zhou","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2016.03.034_bib64","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.euroneuro.2010.07.011","article-title":"Involvement of NMDA receptors and l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effects of escitalopram in the forced swimming test","volume":"20","author":"Zomkowski","year":"2010","journal-title":"Eur. Neuropsychopharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916301571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916301571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T18:08:20Z","timestamp":1655316500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299916301571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":63,"alternative-id":["S0014299916301571"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.03.034","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Involvement of nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of tropisetron and ondansetron in mice forced swimming test and tail suspension test","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.03.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}